Erythroleukemia in the adjuvant treatment of breast cancer.
D000477:Alkylating Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged
D000477:Alkylating Agents; D000970:Antineoplastic Agents